138 related articles for article (PubMed ID: 22112369)
21. Nutrition and sepsis.
Cohen J; Chin DN
World Rev Nutr Diet; 2013; 105():116-125. PubMed ID: 23075593
[TBL] [Abstract][Full Text] [Related]
22. Modified EN support for patients with acute respiratory distress syndrome.
Dickerson RN
JPEN J Parenter Enteral Nutr; 2008; 32(6):671-2. PubMed ID: 18974252
[No Abstract] [Full Text] [Related]
23. Acute lung injury and nutritional support.
Gasperino J; Kvetan V
Crit Care Med; 2006 Apr; 34(4):1265-7. PubMed ID: 16550085
[No Abstract] [Full Text] [Related]
24. Dietary supplementation with eicosapentaenoic acid, but not with other long-chain n-3 or n-6 polyunsaturated fatty acids, decreases natural killer cell activity in healthy subjects aged >55 y.
Thies F; Nebe-von-Caron G; Powell JR; Yaqoob P; Newsholme EA; Calder PC
Am J Clin Nutr; 2001 Mar; 73(3):539-48. PubMed ID: 11237929
[TBL] [Abstract][Full Text] [Related]
25. Diets rich in eicosapentaenoic acid and gamma-linolenic acid affect phospholipid fatty acid composition and production of prostaglandins E1, E2 and E3 in turbot (Scophthalmus maximus), a species deficient in delta 5 fatty acid desaturase.
Bell JG; Tocher DR; MacDonald FM; Sargent JR
Prostaglandins Leukot Essent Fatty Acids; 1995 Oct; 53(4):279-86. PubMed ID: 8577782
[TBL] [Abstract][Full Text] [Related]
26. Rationale and use of n-3 fatty acids in artificial nutrition.
Calder PC
Proc Nutr Soc; 2010 Nov; 69(4):565-73. PubMed ID: 20441676
[TBL] [Abstract][Full Text] [Related]
27. Impact of two pulmonary enteral formulations on nutritional indices and outcomes.
Cohen DA; Byham-Gray L; Denmark RM
J Hum Nutr Diet; 2013 Jun; 26(3):286-93. PubMed ID: 23189938
[TBL] [Abstract][Full Text] [Related]
28. Enteral Immunomodulatory Diet (Omega-3 Fatty Acid, γ-Linolenic Acid and Antioxidant Supplementation) for Acute Lung Injury and Acute Respiratory Distress Syndrome: An Updated Systematic Review and Meta-Analysis.
Li C; Bo L; Liu W; Lu X; Jin F
Nutrients; 2015 Jul; 7(7):5572-85. PubMed ID: 26184293
[TBL] [Abstract][Full Text] [Related]
29. Enteral nutrition with eicosapentaenoic acid, gamma-linolenic acid, and antioxidants reduces alveolar inflammatory mediators and protein influx in patients with acute respiratory distress syndrome.
Pacht ER; DeMichele SJ; Nelson JL; Hart J; Wennberg AK; Gadek JE
Crit Care Med; 2003 Feb; 31(2):491-500. PubMed ID: 12576957
[TBL] [Abstract][Full Text] [Related]
30. Intravenous fish oil in adult intensive care unit patients.
Heller AR
World Rev Nutr Diet; 2015; 112():127-40. PubMed ID: 25471809
[TBL] [Abstract][Full Text] [Related]
31. Immunonutrition for Adults With ARDS: Results From a Cochrane Systematic Review and Meta-Analysis.
Dushianthan A; Cusack R; Burgess VA; Grocott MP; Calder P
Respir Care; 2020 Jan; 65(1):99-110. PubMed ID: 31506339
[TBL] [Abstract][Full Text] [Related]
32. A trial of omega-3 fatty acids for prevention of hypertension.
Dokholyan RS; Albert CM; Appel LJ; Cook NR; Whelton P; Hennekens CH
Am J Cardiol; 2004 Apr; 93(8):1041-3. PubMed ID: 15081453
[TBL] [Abstract][Full Text] [Related]
33. The influence of different combinations of gamma-linolenic, stearidonic and eicosapentaenoic acids on the fatty acid composition of blood lipids and mononuclear cells in human volunteers.
Miles EA; Banerjee T; Calder PC
Prostaglandins Leukot Essent Fatty Acids; 2004 Jun; 70(6):529-38. PubMed ID: 15120716
[TBL] [Abstract][Full Text] [Related]
34. Supplemented gamma-linolenic acid and eicosapentaenoic acid influence bone status in young male rats: effects on free urinary collagen crosslinks, total urinary hydroxyproline, and bone calcium content.
Claassen N; Potgieter HC; Seppa M; Vermaak WJ; Coetzer H; Van Papendorp DH; Kruger MC
Bone; 1995 Apr; 16(4 Suppl):385S-392S. PubMed ID: 7626328
[TBL] [Abstract][Full Text] [Related]
35. Effects of eicosapentaenoic and gamma-linolenic acid on lung permeability and alveolar macrophage eicosanoid synthesis in endotoxic rats.
Mancuso P; Whelan J; DeMichele SJ; Snider CC; Guszcza JA; Claycombe KJ; Smith GT; Gregory TJ; Karlstad MD
Crit Care Med; 1997 Mar; 25(3):523-32. PubMed ID: 9118672
[TBL] [Abstract][Full Text] [Related]
36. Tissue distribution and metabolism of gamma-linolenoyl-3-eicosapentaenoyl propane diol enterally or intravenously administered to mice bearing human pancreatic carcinomas.
De Antueno R; Bai M; Elliot M
Anticancer Res; 1999; 19(3A):2041-8. PubMed ID: 10470146
[TBL] [Abstract][Full Text] [Related]
37. Inhibition of 5-lipoxygenase induces cell death in anti-inflammatory fatty acid-treated HL-60 cells.
Gillis RC; Daley BJ; Enderson BL; Karlstad MD
JPEN J Parenter Enteral Nutr; 2004; 28(5):308-14. PubMed ID: 15449569
[TBL] [Abstract][Full Text] [Related]
38. ω-3 fatty acids, γ-linolenic acid, and antioxidants: immunomodulators or inert dietary supplements?
Schott CK; Huang DT
Crit Care; 2012 Nov; 16(6):325. PubMed ID: 23176247
[TBL] [Abstract][Full Text] [Related]
39. Randomized, double-blind trial of long-chain polyunsaturated fatty acid supplementation with fish oil and borage oil in preterm infants.
Fewtrell MS; Abbott RA; Kennedy K; Singhal A; Morley R; Caine E; Jamieson C; Cockburn F; Lucas A
J Pediatr; 2004 Apr; 144(4):471-9. PubMed ID: 15069395
[TBL] [Abstract][Full Text] [Related]
40. Randomized controlled trial of gamma-linolenic acid and eicosapentaenoic acid in peripheral arterial disease.
Leng GC; Lee AJ; Fowkes FG; Jepson RG; Lowe GD; Skinner ER; Mowat BF
Clin Nutr; 1998 Dec; 17(6):265-71. PubMed ID: 10205349
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
